Study guide

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain

Key Takeaways Explain This Topic AI

Burn pain is a complex, dynamic pathophysiological state driven by peripheral nociceptive sensitization, primary hyperalgesia (lowered nociceptor threshold at the injury site), secondary hyperalgesia (central dorsal horn sensitization), and allodynia.

Burn pain is categorized into four discrete clinical entities: Background (continuous resting pain), Procedural (acute, intense pain from wound care and therapy), Breakthrough (intermittent spikes during movement or medication troughs), and Chronic/Neuropathic (persistent dysesthetic, burning, or phantom pain).

Differentiating burn pain subtypes is essential because each possesses distinct neurobiological mechanisms requiring specific pharmacological and non-pharmacological therapeutic strategies.

Validated, age- and condition-appropriate pain assessment tools must be utilized routinely: NRS or VAS for communicative adults, CPOT or BPS for non-verbal/mechanically ventilated ICU patients, and FLACC or Wong-Baker FACES for pediatric patients.

Pain assessment must be conducted dynamically across the treatment continuum—at baseline rest, immediately prior to interventions, intra-procedurally, and at the post-analgesic peak onset to gauge therapeutic efficacy.

Last updated: August 2026

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain

Core Knowledge: Pain associated with thermal trauma is universally recognized as one of the most severe, excruciating, and protracted forms of acute pain encountered in clinical medicine. Effective burn pain management requires the Certified Burn Registered Nurse (CBRN) to understand that burn pain is not a static, uniform symptom, but a dynamic, evolving neurobiological process comprising four discrete pain subtypes: background pain , procedural pain , breakthrough pain , and chronic neuropathic pain . Successful management hinges upon precise classification, validated assessment across diverse patient populations, and targeted multimodal intervention.

1. Neurobiology of Burn Pain: Peripheral and Central Sensitization

Thermal, chemical, and electrical injuries inflict extensive tissue destruction that simultaneously activates, damages, and sensitizes the peripheral and central nervous systems. NEUROBIOLOGICAL CASCADE OF BURN PAIN

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ CUTANEOUS THERMAL INJURY │
  • └───────────────────────────────────┬────────────────────────────────────┘
  • │
  • ┌──────────────────────────────┴──────────────────────────────┐
  • ▼ ▼
  • ┌───────────────────────────────┐ ┌───────────────────────────────┐
  • │ PRIMARY HYPERALGESIA │ │ SECONDARY HYPERALGESIA │
  • │ (Peripheral Pathway) │ │ (Central Pathway) │
  • ├───────────────────────────────┤ ├───────────────────────────────┤
  • │ • Massive "Inflammatory Soup" │ │ • Sustained C-fiber barrage │
  • │ (Bradykinin, Substance P, │ │ • Dorsal horn WDR neuron │
  • │ Prostaglandins, Histamine, │ │ hyperexcitability (Wind-Up) │
  • │ CGRP, Interleukins, TNF-α) │ │ • NMDA receptor activation & │
  • │ • Lowered threshold of intact │ │ loss of GABAergic inhibition│
  • │ A-delta and C nociceptors │ │ • Amplified pain processing │
  • │ • Intense pain within the │ │ • Spread of pain & ALLODYNIA │
  • │ direct zone of injury │ │ into uninjured tissue │
  • └───────────────────────────────┘ └───────────────────────────────┘
  • Peripheral Nociceptive Sensitization & Primary Hyperalgesia

When thermal energy damages cutaneous architecture, lysed cells, activated platelets, mast cells, and migrating leukocytes flood the local microenvironment with an "inflammatory soup" of algogenic biochemical mediators. Key substances include:

Prostaglandins ( P G E 2 PGE_2 PG E 2 ​ ) and Prostacyclins: Sensitize primary afferent nociceptors to thermal and mechanical stimuli by lowering activation thresholds.

Bradykinin and Histamine: Induce profound vasodilation, microvascular hyperpermeability, and direct depolarization of free nerve endings.

Substance P and Calcitonin Gene-Related Peptide (CGRP): Released via antidromic axon reflexes, triggering neurogenic inflammation , local edema, and recruitment of adjacent silent nociceptors.

Cytokines ( T N F − α , I L − 1 β , I L − 6 TNF-\alpha, IL-1\beta, IL-6 TNF − α , I L − 1 β , I L − 6 ): Upregulate voltage-gated sodium channels ( N a v 1.7 , N a v 1.8 Nav1.7, Nav1.8 N a v 1.7 , N a v 1.8 ), driving persistent spontaneous firing.

This sustained peripheral barrage produces primary hyperalgesia , defined as an exaggerated, heightened pain response to noxious mechanical or thermal stimuli localized directly within the injured burn tissue (Jackson's zone of stasis and zone of hyperemia).

Central Sensitization, "Wind-Up," and Secondary Hyperalgesia

Unrelieved, repetitive C-fiber and A-delta afferent input bombards the dorsal horn of the spinal cord (specifically substantia gelatinosa laminae I, II, and V). This constant barrage triggers profound neuroplastic remodeling:

Dorsal Horn Wind-Up: Prolonged release of glutamate and substance P removes the resting magnesium ( M g 2 + Mg^{2+} M g 2 + ) plug from post-synaptic N-methyl-D-aspartate (NMDA) receptors on Wide Dynamic Range (WDR) neurons. Intracellular calcium surges into the post-synaptic neuron, activating protein kinase C (PKC) and nitric oxide synthase (NOS).

Secondary Hyperalgesia: The receptive fields of dorsal horn neurons expand dramatically. Stimuli applied to undamaged, unburned tissue surrounding the burn now evoke severe pain.

Allodynia: Normally innocuous, non-painful mechanical stimuli (such as the gentle touch of a bedsheet, a light breeze, or ambient temperature fluctuations) stimulate low-threshold A β A\beta A β mechanoreceptor fibers, which are erroneously processed by sensitized central WDR pathways as excruciating pain.

2. The Four Discrete Types of Burn Pain

Burn trauma presents a unique clinical challenge because patients experience multiple distinct pain profiles simultaneously. The Certified Burn Registered Nurse must differentiate these four subtypes to guide pharmacological timing and selection.

Burn Pain Subtype Underlying Mechanism Clinical Presentation & Timing Primary Treatment Strategy

1. Background (Resting) Pain Continuous inflammatory mediator release stimulating exposed nociceptors in partial-thickness zones and viable tissue borders. Constant, dull, throbbing, aching, or burning discomfort present at rest, in the absence of movement or manipulation. Scheduled, long-acting basal analgesia (continuous IV infusions, scheduled oral opioids, methadone, or PCA basal).

2. Procedural Pain Intense mechanical stimulation, direct traction on exposed nerve endings, and thermal exposure during care. Acute, sharp, excruciating, severe pain provoked by wound debridement, dressing changes, hydrotherapy, staple removal, and physical therapy. Rapid-onset, short-acting, potent analgesics (IV fentanyl, sublingual/intranasal opioids, sub-anesthetic ketamine) timed to peak drug levels.

3. Breakthrough Pain Transient exacerbation of pain exceeding baseline control; physical movement or wearing off of baseline analgesia. Sudden, sharp spikes in pain occurring during routine coughing, deep breathing, repositioning, or near the end of a dosing interval. Rapid-acting, short-duration PRN rescue opioids (oral liquid or IV push) dosed proportional to the baseline opioid regimen.

4. Chronic / Neuropathic Pain Nerve transection, entrapment within rigid hypertrophic scars, aberrant regenerating nerve sprouts (neuromas), and central sensitization. Burning, shooting, electric shocks, tingling, dysesthesias, numbness, or phantom limb/skin sensations persisting weeks to years post-burn. Gabapentinoids (gabapentin, pregabalin), tricyclic antidepressants, SNRIs, topical lidocaine, and desensitization therapy.

Background (Resting) Pain

Background pain represents the baseline level of discomfort experienced by the patient throughout the day and night while stationary. It is driven by continuous tissue inflammation, metabolic acidosis in the wound bed, and ongoing tissue edema. Because background pain persists for weeks to months until complete wound closure is achieved, it must be managed with around-the-clock, scheduled basal analgesia rather than reactive, as-needed (PRN) administration. Under-treating background pain accelerates central sensitization and amplifies procedural pain.

Procedural Pain

Procedural pain is universally reported by burn survivors as the most traumatic aspect of acute hospitalization. Wound cleansing, mechanical debridement, surgical dressing changes, donor site care, staple removal, and aggressive physical/occupational therapy (joint range of motion) produce excruciating pain that easily overwhelms background analgesia. Procedural pain is characterized by rapid onset, extreme intensity, and potential for severe anticipatory anxiety. Pharmacological agents must be administered in advance to ensure that the peak serum drug concentration coincides precisely with the start of the painful procedure .

Breakthrough Pain

Breakthrough pain refers to transient, sudden flares of moderate-to-severe pain that occur despite adequate baseline background pain control. It may be incident-related (triggered by purposeful activities such as coughing, ambulation, or eating) or end-of-dose failure (occurring when baseline analgesic concentrations drop below the minimum effective concentration prior to the next scheduled dose). Managing breakthrough pain requires immediate-release rescue analgesics that can be administered without delaying the scheduled background regimen.

Chronic and Neuropathic Pain

As acute burn wounds re-epithelialize and undergo scar remodeling, pain mechanisms transition from purely nociceptive to neuropathic. Cutaneous nerve terminals damaged by partial- and full-thickness burns generate abnormal spontaneous axonal discharges. Regenerating unmyelinated nerve sprouts become entrapped within dense, contracted type I collagen bundles of hypertrophic scars, forming micro-neuromas. Patients describe constant "pins and needles," electric shooting sensations, extreme itching (prurigo), or painful cold sensitivity. Standard opioid therapy is notoriously ineffective for pure neuropathic pain, necessitating early initiation of neuromodulatory agents.

3. Validated Pain Assessment Instruments in Burn Care

Objective, systematic pain assessment is the cornerstone of effective analgesia. The CBRN must select validated instruments tailored to the patient's age, cognitive baseline, communicative ability, and clinical acuity. PAIN ASSESSMENT TOOL SELECTION HIERARCHY

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ PATIENT ABLE TO SELF-REPORT? │
  • └───────────────────────────────────┬────────────────────────────────────┘
  • │
  • ┌───────────────────┴───────────────────┐
  • ▼ ▼
  • [ YES ] [ NO ]
  • │ │
  • ┌────────┴────────┐ ┌────────┴────────┐
  • ▼ ▼ ▼ ▼
  • ┌─────────────┐ ┌─────────────┐ ┌─────────────┐ ┌─────────────┐
  • │ Adult / Adol│ │ Pediatric │ │ Critically │ │ Pediatric │
  • │ (Age ≥ 8) │ │ (Age 3 – 7) │ │ Ill / Intub │ │ (Age < 4) │
  • ├─────────────┤ ├─────────────┤ ├─────────────┤ ├─────────────┤
  • │ • Numeric │ │ • Wong-Baker│ │ • CPOT │ │ • FLACC │
  • │ Rating │ │ FACES │ │ (Critical │ │ Scale │
  • │ Scale │ │ Scale │ │ Care Pain │ │ (Face, │
  • │ (NRS 0-10)│ │ • Numeric │ │ Observat. │ │ Legs, │
  • │ • Visual │ │ (if cog. │ │ Tool) │ │ Activity, │
  • │ Analog │ │ mature) │ │ • BPS │ │ Cry, │
  • │ Scale │ │ │ │ (Behavior │ │ Consol- │
  • │ (VAS mm) │ │ │ │ Pain Scl) │ │ ability) │
  • └─────────────┘ └─────────────┘ └─────────────┘ └─────────────┘
  • 1. Communicative Adults and Adolescents

Numeric Rating Scale (NRS 0–10): The gold-standard self-report tool where 0 represents "no pain" and 10 represents the "worst pain imaginable." Validated, highly reliable, and sensitive to acute therapeutic changes.

Visual Analog Scale (VAS 0–100 mm): A 10-cm horizontal line with verbal anchors at each end. The patient marks their pain intensity, which is measured in millimeters. Highly useful in research and clinical tracking but requires intact fine motor coordination and clear visual fields (often compromised in facial/hand burns).

2. Non-Verbal, Mechanically Ventilated, or Critically Ill Adults

In intubated, heavily sedated, or delirious patients who cannot self-report, physiological parameters (vital signs such as heart rate and blood pressure) are non-specific and must never be used alone to evaluate pain. Clinicians must utilize validated behavioral observation instruments:

Critical Care Pain Observation Tool (CPOT): Evaluates four behavioral domains on a 0–2 scale (Total score range: 0 to 8; a score > 2 >2 > 2 indicates significant pain):

  • CPOT Domain Score 0 Score 1 Score 2
  • Facial Expression Relaxed, neutral Tense, frowning, brow lowering Grimacing, eyes tightly closed, tearing

Body Movements Absence of movements, relaxed Slow, cautious movements, touching wound Restless, thrashing, pulling lines/tubes

Muscle Tension (Passive arm flexion/extension) Relaxed, no resistance Tense, rigid, mild resistance to passive movement Very tense, rigid, strong resistance, clenching

Ventilator Compliance (Intubated) OR Vocalization (Extubated) Alarms not activated, easy ventilation; OR normal talking/quiet Coughing, alarms activate but stop spontaneously; OR sighing, moaning Fighting ventilator, dyssynchrony, persistent alarms; OR crying out, sobbing

Behavioral Pain Scale (BPS): Evaluates facial expression, upper limb movements, and mechanical ventilation compliance (Score range: 3 to 12; score > 5 >5 > 5 reflects unacceptable pain).

3. Pediatric Burn Populations

FLACC Scale (Face, Legs, Activity, Cry, Consolability): Validated for infants, toddlers, and young children aged 2 months to 7 years (or non-verbal cognitively impaired patients). Each category is scored 0 to 2 (Total score: 0 to 10).

Wong-Baker FACES Pain Rating Scale: Validated for verbal children aged 3 to 8 years. Utilizes six drawn cartoon faces ranging from a happy, smiling face (0 = "No hurt") to a crying, tearful face (10 = "Hurts worst"). Nurses must explain that the faces depict how the child feels inside , not how their face looks.

4. Assessment Timing and Documentation Protocols

Burn pain assessment must be dynamic, continuous, and integrated into every stage of clinical care. Standardized assessment intervals include:

Baseline / Resting State: Assessed every 2 to 4 hours to evaluate background pain control.

Pre-Procedural Assessment: Recorded 15 to 30 minutes prior to planned interventions (wound debridement, dressing changes, line placements, or physical therapy) to guide pre-medication dosing.

Intra-Procedural Monitoring: Continuous observation during interventions to identify sudden breakthrough distress requiring supplemental rescue analgesia.

Post-Intervention Peak Evaluation: Assessed at the anticipated peak pharmacological onset of the administered analgesic (10–15 minutes after IV opioids/ketamine; 45–60 minutes after oral analgesics) to verify therapeutic efficacy.

Post-Procedure Recovery: Documented 30 to 60 minutes following the conclusion of the procedure to ensure resolution of procedural spikes and return to baseline comfort.